The work of the Action Mental Health Programmes has been supported by membership fees, contributions from the Collegium Internationale Neuropsychopharmacologicum (CINP), donations by members of the AIMHP, contributions from various institutions and universities in the form of staff time and facilities, as well as through grants received from Eli Lilly and Company, the Lundbeck International Neuroscience Foundation, Pfizer and Wyeth Pharmaceuticals. The funds received are used exclusively to support AIMHP projects. No members of the AIMHP receive salaries or honoraria for their work on AIMHP projects.